190 related articles for article (PubMed ID: 11176266)
1. Prevalence and correlates of anemia in a large cohort of HIV-infected women: Women's Interagency HIV Study.
Levine AM; Berhane K; Masri-Lavine L; Sanchez M; Young M; Augenbraun M; Cohen M; Anastos K; Newman M; Gange SJ; Watts H
J Acquir Immune Defic Syndr; 2001 Jan; 26(1):28-35. PubMed ID: 11176266
[TBL] [Abstract][Full Text] [Related]
2. Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV Study.
Berhane K; Karim R; Cohen MH; Masri-Lavine L; Young M; Anastos K; Augenbraun M; Watts DH; Levine AM
J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1245-52. PubMed ID: 15385731
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors influencing peak viral load drop in response to nucleoside reverse transcriptase inhibitors in antiretroviral-naive HIV-1-infected patients.
Vidal C; García F; Gatell JM; Leal M; Clotet B; Pumarola T; Miró JM; Mallolas J; Ruiz L; Cruceta A; Tortajada C
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep; 19(1):55-60. PubMed ID: 9732070
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 reverse transcriptase codon 215 mutation in plasma RNA: immunologic and virologic responses to zidovudine. The AIDS Clinical Trials Group Study 175 Virology Team.
Rey D; Hughes M; Pi JT; Winters M; Merigan TC; Katzenstein DA
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):203-8. PubMed ID: 9495218
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human-immunodeficiency-virus-infected patients: findings of the Anemia Prevalence Study.
Mildvan D; Creagh T; Leitz G;
Curr Med Res Opin; 2007 Feb; 23(2):343-55. PubMed ID: 17288689
[TBL] [Abstract][Full Text] [Related]
6. Improvement of anemia among HIV-infected injection drug users receiving highly active antiretroviral therapy.
Semba RD; Shah N; Vlahov D
J Acquir Immune Defic Syndr; 2001 Apr; 26(4):315-9. PubMed ID: 11317071
[TBL] [Abstract][Full Text] [Related]
7. Magnitude and correlates of moderate to severe anemia among adult HIV patients receiving first line HAART in Northwestern Tanzania: a cross sectional clinic based study.
Gunda DW; Kilonzo SB; Mpondo BC
Pan Afr Med J; 2016; 23():26. PubMed ID: 27200131
[TBL] [Abstract][Full Text] [Related]
8. Mean corpuscular volume (MCV) values reflect therapeutic effectiveness in zidovudine-receiving HIV patients.
Kim AH; Jang W; Kim Y; Park YJ; Han K; Oh EJ
J Clin Lab Anal; 2013 Sep; 27(5):373-8. PubMed ID: 24038222
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995--1999.
Sitnitskaya Y; Rochford G; Rigaud M; Essajee S; Pollack H; Krasinski K; Borkowsky W
Clin Infect Dis; 2001 Jul; 33(1):e3-7. PubMed ID: 11389511
[TBL] [Abstract][Full Text] [Related]
10. Hematological abnormalities in HIV-infected patients.
De Santis GC; Brunetta DM; Vilar FC; Brandão RA; de Albernaz Muniz RZ; de Lima GM; Amorelli-Chacel ME; Covas DT; Machado AA
Int J Infect Dis; 2011 Dec; 15(12):e808-11. PubMed ID: 21880530
[TBL] [Abstract][Full Text] [Related]
11. Anemia in people on second line antiretroviral treatment in Lilongwe, Malawi: a cross-sectional study.
Ngongondo M; Rosenberg NE; Stanley CC; Lim R; Ongubo D; Broadhurst R; Speight C; Flick R; Tembo P; Hosseinpour MC
BMC Infect Dis; 2018 Jan; 18(1):39. PubMed ID: 29334932
[TBL] [Abstract][Full Text] [Related]
12. Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working Group.
Phillips AN; Eron J; Bartlett J; Kuritzkes DR; Johnson VA; Gilbert C; Johnson J; Keller A; Hill AM
AIDS; 1997 Feb; 11(2):169-75. PubMed ID: 9030363
[TBL] [Abstract][Full Text] [Related]
13. Genotypic resistance to zidovudine as a predictor of failure of subsequent therapy with human immunodeficiency virus type-1 nucleoside reverse-transcriptase inhibitors.
Venturi G; Romano L; Catucci M; Riccio ML; De Milito A; Gonnelli A; Rubino M; Valensin PE; Zazzi M
Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):274-82. PubMed ID: 10385016
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.
Welles SL; Pitt J; Colgrove R; McIntosh K; Chung PH; Colson A; Lockman S; Fowler MG; Hanson C; Landesman S; Moye J; Rich KC; Zorrilla C; Japour AJ
AIDS; 2000 Feb; 14(3):263-71. PubMed ID: 10716502
[TBL] [Abstract][Full Text] [Related]
15. Anaemia in pregnancy is associated with advanced HIV disease.
Nandlal V; Moodley D; Grobler A; Bagratee J; Maharaj NR; Richardson P
PLoS One; 2014; 9(9):e106103. PubMed ID: 25222119
[TBL] [Abstract][Full Text] [Related]
16. Zidovudine genotypic resistance in HIV-1-infected newborns in the French perinatal cohort.
Masquelier B; Chaix ML; Burgard M; Lechenadec J; Doussin A; Simon F; Cottalorda J; Izopet J; Tamalet C; Douard D; Fleury H; Mayaux MJ; Blanche S; Rouzioux C;
J Acquir Immune Defic Syndr; 2001 Jun; 27(2):99-104. PubMed ID: 11404530
[TBL] [Abstract][Full Text] [Related]
17. Current hemoglobin levels are more predictive of disease progression than hemoglobin measured at baseline in patients receiving antiretroviral treatment for HIV type 1 infection.
Kowalska JD; Mocroft A; Blaxhult A; Colebunders R; van Lunzen J; Podlekareva D; Hansen AB; Machala L; Yust I; Benfield T;
AIDS Res Hum Retroviruses; 2007 Oct; 23(10):1183-8. PubMed ID: 17961102
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.
Ssali F; Stöhr W; Munderi P; Reid A; Walker AS; Gibb DM; Mugyenyi P; Kityo C; Grosskurth H; Hakim J; Byakwaga H; Katabira E; Darbyshire JH; Gilks CF;
Antivir Ther; 2006; 11(6):741-9. PubMed ID: 17310818
[TBL] [Abstract][Full Text] [Related]
19. Sustained high proportion of zidovudine-resistant HIV variants despite prolonged substitution of zidovudine by other nucleoside reverse transcriptase inhibitors.
Bélec L; Legoff J; Si-Mohamed A; Andréoletti L; Mbopi-Kéou FX; Kolberg J; Matta M; Detmer J; Piketty C; Kazatchkine MD
J Med Virol; 2002 Sep; 68(1):1-6. PubMed ID: 12210423
[TBL] [Abstract][Full Text] [Related]
20. Anemia in HIV-infected patients receiving highly active antiretroviral therapy.
Moore RD; Forney D
J Acquir Immune Defic Syndr; 2002 Jan; 29(1):54-7. PubMed ID: 11782590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
